Sfoglia per AUTORE
ZAZZI M
Collezione ASL Città di Torino

  

Items : 12

Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells. in The Journal of general virology / J Gen Virol. 2021 Jan;102(1). doi: 10.1099/jgv.0.001499.

2021
ASL Città di Torino

Montomoli E; Orofino G; Medaglini D; Pastore G; Vicenti I; Dragoni F; Trombetta CM; Giannini A; De Luca A; Ciabattini A; Rossetti B; Saladini F; Boccuto A; Monti M; Zazzi M;

VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Digestive and Liver Disease

2020
ASL Città di Torino

Ceccherini-Silberstein F; Craxì A; Perno CF; Angelico M; Andreoni M; Zazzi M; Raimondo G; Puoti M; Gaeta GB; Baldanti F; Coppola N; Parruti G; Lampertico P; Ghisetti V; Beretta I; Cariti G; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Giorgini A; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Giannelli V; Rizzardini G; Ganga R; et alii...

Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience in Journal of Hepatology

2019
ASL Città di Torino

Francesca Ceccherini S; Mario A; Federico Perno C; Andreoni M; Craxi A; Raimondo G; Zazzi M; Nicola C; Parruti G; Pellicelli A; Lampertico P; Rizzardini G; Ganga R; Puoti M; Paternoster C; Taliani G; Santantonio T; Babudieri S; De Santis A; Lichtner M; Cozzolongo R; Brunetto M; Borghi V; Rita Maida I; Morsica G; Sangiovanni V; Cuomo N; Ciancio A; Andreone P; et alii...

Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience in Digestive and Liver Disease

2019
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Craxì A; Angelico M; Andreoni M; Raimondo G; Zazzi M; Coppola N; Parruti G; Giorgini A; Lampertico P; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Santantonio T; Di Stefano M; Taliani G; Babudieri S; Lichtner M; De Santis A; Cozzolongo R; Colombatto P; Brunetto M; et alii...

Decline of prevalence of resistance associated substitutions to NS3 and NS5A inhibitors at DAA failure in hepatitis C virus in Italy over the years 2015 to 2018 in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Zazzi M; Craxì A; Federico Perno C; Angelico M; Andreoni M; Rizzardini G; Raimondo G; Battista Gaeta G; Lampertico P; Babudieri S; Caudai C; Cuomo N; Santantonio TA; Pollicino T; Brunetto MR; Andreone P; Borghi V; Aghemo A; Ciancio A; Cariti G; Giorgini A; Palitti VP; Ciaccio A; Licata A; Lenci I; Biolato M; Sangiovanni V; Prestileo T; et alii...

Italian real life experience of resistanceguided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Perno CF; Craxì A; Angelico M; Andreoni M; Zazzi M; Raimondo G; Coppola N; Parruti G; Lampertico P; Beretta I; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Di Lorenzo F; Giorgini A; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Di Stefano M; Santantonio TA; Taliani G; Biliotti E; et alii...

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? in Journal of hepatology / J Hepatol. 2018 Mar;68(3):597-600. doi: 10.1016/j.jhep.2017.09.008. Epub 2017 Sep 20.

2018
ASL Città di Torino

Ceccherini-Silberstein F; Baldanti F; Raimondo G; Perno CF; Barbaliscia S; Galli S; Gennari W; Zazzi M; Brunetto M; Bertoli A; Coppola N; Bruzzone B; Ghisetti V; Di Maio VC; Pollicino T; Paolucci S; Aragri M; Cento V;

Comparison of resistance profiles among DAA-naive and DAAexperienced patients infected with HCV non-1 genotype in Italy in Journal of Hepatology

2018
ASL Città di Torino

Silberstein FC; Cento V; Perno CF; Andreoni M; Angelico M; Sarmati L; Parruti G; Pasquazzi C; Craxi A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Rendina MG; Pellicelli A; Gubertini GA; Babudieri S; Bonora S; Boglione L; D'ambrosio R; Vullo V; Rossetti B; Zazzi M; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing in Digestive and Liver Disease

2018
ASL Città di Torino

Craxì A; Perno CF; Ceccherini-Silberstein F; Zazzi M; Vatteroni ML; Starace M; Soldini S; Santangelo R; Santantonio T; Sanguinetti M; Sampaolo M; Raimondo G; Raffa G; Raddi A; Pollicino T; Paolucci S; Monno L; Micheli V; Minosse C; Menzo S; Lai A; Gennari W; Garbuglia AR; Galmozzi E; Galli S; Cuomo N; Caudai C; Capobianchi MR; Callegaro AP; et alii...

Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy in Digestive and Liver Disease

2018
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Cento V; Andreoni M; Angelico M; Parruti G; Sarmati L; Pasquazzi C; Craxì A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Pellicelli A; Rendina M; Gubertini G; Babudieri S; Bonora S; Boglione L; D'Ambrosio AR; Vullo V; Zazzi M; Rossetti B; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing in Journal of Hepatology

2018
ASL Città di Torino

Zazzi M; Silberstein FC; Perno CF; Craxi A; Vatteroni ML; Starace M; Soldini S; Santantonio T; Santangelo R; Sanguinetti M; Raimondo G; Raffa G; Raddi A; Pollicino T; Paolucci S; Monno L; Minosse C; Micheli V; Menzo S; Lai A; Gennari W; Garbuglia A; Galmozzi E; Galli S; Cuomo N; Caudai C; Capobianchi MR; Callegaro MP; Ghisetti V; et alii...

Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. in PloS one / PLoS One. 2017 Nov 21;12(11):e0187393. doi: 10.1371/journal.pone.0187393. eCollection 2017.

2017
ASL Città di Torino

Rossetti B; Gagliardini R; Meini G; Sterrantino G; Colangeli V; Re MC; Latini A; Colafigli M; Vignale F; Rusconi S; Micheli V; Di Biagio A; Orofino G; Ghisetti V; Fantauzzi A; Vullo V; Grima P; Francisci D; Mastroianni C; Antinori A; Trezzi M; Lisi L; Navarra P; Canovari B; D'Arminio Monforte A; Lamonica S; D'Avino A; Zazzi M; Di Giambenedetto S; et alii...